“…By combining optical contrast and US resolution, PAI offers several advantages: (i) it is noninvasive and uses nonionizing radiation, hence it can be repeatedly used in vivo by keeping the excitation energy below the safety limit; (ii) it provides label-free imaging; (iii) it is speckle-free; (iv) it has higher penetration depth, up to ∼4 cm in vivo 36 and ∼12 cm in vitro; 37 (v) it is faster and less expensive compared to MRI, PET, x-ray CT; 38 (vi) it provides multiscale imaging, allows imaging organelles to organs with consistent contrast while keeping the same depth-toresolution ratio; 38,39 (vii) it provides direct imaging of optical absorption with 100% relative sensitivity-the sensitivity of PAI is 100 times higher than that of OCT and confocal microscopy; and (viii) it provides anatomical, functional, molecular, and kinetic information. 40 PAI was successfully implemented as photoacoustic nanoscopy, [41][42][43][44][45][46] photoacoustic microscopy (PAM), [47][48][49][50][51][52] photoacoustic endoscopy, [53][54][55][56] preclinical photoacoustic computed tomography/photoacoustic tomography *Address all correspondence to Manojit Pramanik, E-mail: manojit@ntu.edu.sg (PACT/PAT), [57][58][59][60][61][62] and clinical PACT. [63][64][65][66][67][68] For deep-tissue imaging, PACT/PAT systems are suitable and hence hold better chance to find preclinical/clinical applications.…”